These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
x
|
Quarterly Report Pursuant to Section 13 or 15(d)
of the
Securities Exchange Act of 1934
For the Quarterly Period Ended October 31, 2016
|
|
|
o
|
Transition Report Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
For the transition period from _____________ to ______________
|
|
|
Delaware
(State or other jurisdiction of incorporation or
organization)
|
|
36-2048898
(I.R.S. Employer
Identification No.)
|
|
|
|
|
|
410 North Michigan Avenue, Suite 400
Chicago, Illinois
(Address of principal executive offices)
|
|
60611-4213
(Zip Code)
|
|
Large accelerated filer
o
|
Accelerated filer
x
|
Non-accelerated filer
o
|
Smaller reporting company
o
|
|
|
|
|
|
|
PART I – FINANCIAL INFORMATION
|
|
|
|
|
Page
|
|
Item 1:
|
||
|
|
|
|
|
Item 2:
|
||
|
|
|
|
|
Item 3:
|
||
|
|
|
|
|
Item 4:
|
||
|
|
|
|
|
|
PART II – OTHER INFORMATION
|
|
|
|
|
|
|
Item 2:
|
Unregistered Sales of Equity Securities and Use of Proceeds
|
|
|
|
|
|
|
Item 4:
|
||
|
|
|
|
|
Item 6:
|
||
|
|
|
|
|
|
||
|
|
(unaudited)
|
|
|
||||
|
ASSETS
|
October 31,
2016 |
|
July 31,
2016 |
||||
|
Current Assets
|
|
|
|
||||
|
Cash and cash equivalents
|
$
|
15,991
|
|
|
$
|
18,629
|
|
|
Short-term investments
|
5,359
|
|
|
10,184
|
|
||
|
Accounts receivable, less allowance of
$801 and $753 at October 31, 2016 and July 31, 2016, respectively |
30,971
|
|
|
30,386
|
|
||
|
Inventories
|
23,567
|
|
|
23,251
|
|
||
|
Deferred income taxes
|
3,884
|
|
|
3,884
|
|
||
|
Prepaid repairs expense
|
4,235
|
|
|
3,938
|
|
||
|
Prepaid expenses and other assets
|
1,992
|
|
|
901
|
|
||
|
Total Current Assets
|
85,999
|
|
|
91,173
|
|
||
|
|
|
|
|
||||
|
Property, Plant and Equipment
|
|
|
|
|
|
||
|
Cost
|
221,164
|
|
|
218,025
|
|
||
|
Less accumulated depreciation and amortization
|
(139,476
|
)
|
|
(137,314
|
)
|
||
|
Total Property, Plant and Equipment, Net
|
81,688
|
|
|
80,711
|
|
||
|
|
|
|
|
||||
|
Other Assets
|
|
|
|
|
|
||
|
Goodwill
|
9,034
|
|
|
9,034
|
|
||
|
Trademarks and patents, net of accumulated amortization
of $269 and $261 at October 31, 2016 and July 31, 2016, respectively |
979
|
|
|
916
|
|
||
|
Customer list, net of accumulated amortization
of $3,745 and $3,460 at October 31, 2016 and July 31, 2016, respectively |
4,040
|
|
|
4,325
|
|
||
|
Deferred income taxes
|
12,387
|
|
|
12,754
|
|
||
|
Other
|
5,940
|
|
|
5,902
|
|
||
|
Total Other Assets
|
32,380
|
|
|
32,931
|
|
||
|
|
|
|
|
||||
|
Total Assets
|
$
|
200,067
|
|
|
$
|
204,815
|
|
|
|
(unaudited)
|
|
|
||||
|
LIABILITIES & STOCKHOLDERS’ EQUITY
|
October 31,
2016 |
|
July 31,
2016 |
||||
|
Current Liabilities
|
|
|
|
||||
|
Current maturities of notes payable
|
$
|
3,083
|
|
|
$
|
3,083
|
|
|
Accounts payable
|
6,910
|
|
|
6,635
|
|
||
|
Dividends payable
|
1,479
|
|
|
1,477
|
|
||
|
Accrued expenses:
|
|
|
|
|
|||
|
Salaries, wages and commissions
|
4,263
|
|
|
8,656
|
|
||
|
Trade promotions and advertising
|
3,076
|
|
|
2,855
|
|
||
|
Freight
|
1,378
|
|
|
1,579
|
|
||
|
Other
|
7,138
|
|
|
6,455
|
|
||
|
Total Current Liabilities
|
27,327
|
|
|
30,740
|
|
||
|
|
|
|
|
||||
|
Noncurrent Liabilities
|
|
|
|
|
|
||
|
Notes payable, net of unamortized debt issuance costs
of $110 and $118 at October 31, 2016 and July 31, 2016, respectively |
9,140
|
|
|
12,215
|
|
||
|
Deferred compensation
|
10,778
|
|
|
10,504
|
|
||
|
Pension and postretirement benefits
|
32,687
|
|
|
32,492
|
|
||
|
Other
|
3,361
|
|
|
3,313
|
|
||
|
Total Noncurrent Liabilities
|
55,966
|
|
|
58,524
|
|
||
|
|
|
|
|
||||
|
Total Liabilities
|
83,293
|
|
|
89,264
|
|
||
|
|
|
|
|
||||
|
Stockholders’ Equity
|
|
|
|
|
|
||
|
Common Stock, par value $.10 per share, issued 7,997,166 shares at October 31, 2016
and 7,982,243 shares at July 31, 2016 |
800
|
|
|
798
|
|
||
|
Class B Stock, par value $.10 per share, issued 2,513,512 shares at October 31, 2016
and 2,515,735 shares at July 31, 2016 |
251
|
|
|
252
|
|
||
|
Additional paid-in capital
|
34,853
|
|
|
34,294
|
|
||
|
Retained earnings
|
150,475
|
|
|
149,945
|
|
||
|
Accumulated other comprehensive loss:
|
|
|
|
|
|
||
|
Pension and postretirement benefits
|
(13,598
|
)
|
|
(13,867
|
)
|
||
|
Cumulative translation adjustment
|
(169
|
)
|
|
(155
|
)
|
||
|
Total accumulated other comprehensive loss
|
(13,767
|
)
|
|
(14,022
|
)
|
||
|
Less Treasury Stock, at cost (2,916,477 Common and 324,741 Class B shares at
October 31, 2016 and 2,912,953 Common and 324,741 Class B shares at July 31, 2016) |
(55,838
|
)
|
|
(55,716
|
)
|
||
|
Total Stockholders’ Equity
|
116,774
|
|
|
115,551
|
|
||
|
|
|
|
|
||||
|
Total Liabilities & Stockholders’ Equity
|
$
|
200,067
|
|
|
$
|
204,815
|
|
|
|
(unaudited)
|
||||||
|
|
For the Three Months Ended October 31,
|
||||||
|
|
2016
|
|
2015
|
||||
|
|
|
|
|
||||
|
Net Sales
|
$
|
66,612
|
|
|
$
|
67,795
|
|
|
Cost of Sales
|
(45,887
|
)
|
|
(47,142
|
)
|
||
|
Gross Profit
|
20,725
|
|
|
20,653
|
|
||
|
Selling, General and Administrative Expenses
|
(17,679
|
)
|
|
(12,877
|
)
|
||
|
Income from Operations
|
3,046
|
|
|
7,776
|
|
||
|
|
|
|
|
||||
|
Other Income (Expense)
|
|
|
|
|
|
||
|
Interest expense
|
(251
|
)
|
|
(259
|
)
|
||
|
Interest income
|
8
|
|
|
3
|
|
||
|
Other, net
|
(124
|
)
|
|
20
|
|
||
|
Total Other Expense, Net
|
(367
|
)
|
|
(236
|
)
|
||
|
|
|
|
|
||||
|
Income Before Income Taxes
|
2,679
|
|
|
7,540
|
|
||
|
Income Taxes
|
(670
|
)
|
|
(2,117
|
)
|
||
|
Net Income
|
2,009
|
|
|
5,423
|
|
||
|
|
|
|
|
||||
|
Retained Earnings:
|
|
|
|
||||
|
Balance at beginning of period
|
149,945
|
|
|
142,095
|
|
||
|
Cash dividends declared and treasury stock issuances
|
(1,479
|
)
|
|
(1,438
|
)
|
||
|
Balance at End of Period
|
$
|
150,475
|
|
|
$
|
146,080
|
|
|
|
|
|
|
||||
|
Net Income Per Share
|
|
|
|
||||
|
Basic Common
|
$
|
0.30
|
|
|
$
|
0.82
|
|
|
Basic Class B Common
|
$
|
0.23
|
|
|
$
|
0.61
|
|
|
Diluted Common
|
$
|
0.28
|
|
|
$
|
0.75
|
|
|
Average Shares Outstanding
|
|
|
|
||||
|
Basic Common
|
5,004
|
|
|
4,975
|
|
||
|
Basic Class B Common
|
2,067
|
|
|
2,037
|
|
||
|
Diluted Common
|
7,138
|
|
|
7,063
|
|
||
|
Dividends Declared Per Share
|
|
|
|
||||
|
Basic Common
|
$
|
0.2200
|
|
|
$
|
0.2100
|
|
|
Basic Class B Common
|
$
|
0.1650
|
|
|
$
|
0.1575
|
|
|
|
(unaudited)
|
||||||
|
|
For the Three Months Ended October 31,
|
||||||
|
|
2016
|
|
2015
|
||||
|
|
|
|
|
||||
|
Net Income
|
$
|
2,009
|
|
|
$
|
5,423
|
|
|
|
|
|
|
||||
|
Other Comprehensive Income:
|
|
|
|
||||
|
Pension and postretirement benefits (net of tax)
|
269
|
|
|
178
|
|
||
|
Cumulative translation adjustment
|
(14
|
)
|
|
(11
|
)
|
||
|
Other Comprehensive Income
|
255
|
|
|
167
|
|
||
|
Total Comprehensive Income
|
$
|
2,264
|
|
|
$
|
5,590
|
|
|
|
(unaudited)
|
||||||
|
|
For the Three Months Ended October 31,
|
||||||
|
CASH FLOWS FROM OPERATING ACTIVITIES
|
2016
|
|
2015
|
||||
|
Net Income
|
$
|
2,009
|
|
|
$
|
5,423
|
|
|
Adjustments to reconcile net income to net cash provided by operating activities:
|
|
|
|
|
|
||
|
Depreciation and amortization
|
3,159
|
|
|
2,939
|
|
||
|
Amortization of investment net discount
|
(2
|
)
|
|
—
|
|
||
|
Non-cash stock compensation expense
|
431
|
|
|
332
|
|
||
|
Excess tax benefits for share-based payments
|
(128
|
)
|
|
(17
|
)
|
||
|
Deferred income taxes
|
165
|
|
|
109
|
|
||
|
Provision for bad debts and cash discounts
|
48
|
|
|
(22
|
)
|
||
|
Loss on the sale of fixed assets
|
161
|
|
|
23
|
|
||
|
(Increase) Decrease in assets:
|
|
|
|
|
|
||
|
Accounts receivable
|
(688
|
)
|
|
(414
|
)
|
||
|
Inventories
|
(367
|
)
|
|
(126
|
)
|
||
|
Prepaid expenses
|
(1,057
|
)
|
|
(862
|
)
|
||
|
Other assets
|
(114
|
)
|
|
(47
|
)
|
||
|
Increase (Decrease) in liabilities:
|
|
|
|
|
|
||
|
Accounts payable
|
476
|
|
|
387
|
|
||
|
Accrued expenses
|
(3,592
|
)
|
|
33
|
|
||
|
Deferred compensation
|
274
|
|
|
86
|
|
||
|
Pension and postretirement benefits
|
464
|
|
|
432
|
|
||
|
Other liabilities
|
86
|
|
|
240
|
|
||
|
Total Adjustments
|
(684
|
)
|
|
3,093
|
|
||
|
Net Cash Provided by Operating Activities
|
1,325
|
|
|
8,516
|
|
||
|
|
|
|
|
||||
|
CASH FLOWS FROM INVESTING ACTIVITIES
|
|
|
|
|
|
||
|
Capital expenditures
|
(4,295
|
)
|
|
(1,765
|
)
|
||
|
Proceeds from sale of property, plant and equipment
|
1
|
|
|
—
|
|
||
|
Purchases of short-term investments
|
(5,119
|
)
|
|
(1,690
|
)
|
||
|
Dispositions of short-term investments
|
9,946
|
|
|
490
|
|
||
|
Net Cash Provided by (Used in) Investing Activities
|
533
|
|
|
(2,965
|
)
|
||
|
|
|
|
|
||||
|
CASH FLOWS FROM FINANCING ACTIVITIES
|
|
|
|
|
|
||
|
Principal payments on notes payable
|
(3,083
|
)
|
|
(3,484
|
)
|
||
|
Dividends paid
|
(1,477
|
)
|
|
(1,377
|
)
|
||
|
Purchase of treasury stock
|
(122
|
)
|
|
(18
|
)
|
||
|
Proceeds from issuance of common stock
|
—
|
|
|
185
|
|
||
|
Excess tax benefits for share-based payments
|
128
|
|
|
17
|
|
||
|
Net Cash Used in Financing Activities
|
(4,554
|
)
|
|
(4,677
|
)
|
||
|
Effect of exchange rate changes on cash and cash equivalents
|
58
|
|
|
(1
|
)
|
||
|
Net (Decrease) Increase in Cash and Cash Equivalents
|
(2,638
|
)
|
|
873
|
|
||
|
Cash and Cash Equivalents, Beginning of Period
|
18,629
|
|
|
20,138
|
|
||
|
Cash and Cash Equivalents, End of Period
|
$
|
15,991
|
|
|
$
|
21,011
|
|
|
|
(unaudited)
|
||||||
|
|
For the Three Months Ended October 31,
|
||||||
|
|
2016
|
|
2015
|
||||
|
Supplemental disclosure of non-cash investing and financing activities:
|
|
|
|
||||
|
Capital expenditures accrued, but not paid
|
$
|
821
|
|
|
$
|
192
|
|
|
Cash dividends declared and accrued, but not paid
|
$
|
1,479
|
|
|
$
|
1,406
|
|
|
|
October 31,
2016 |
|
July 31,
2016 |
||||
|
Finished goods
|
$
|
13,740
|
|
|
$
|
14,032
|
|
|
Packaging
|
4,966
|
|
|
4,672
|
|
||
|
Other
|
4,861
|
|
|
4,547
|
|
||
|
Total Inventories
|
$
|
23,567
|
|
|
$
|
23,251
|
|
|
2018
|
$
|
1,013
|
|
|
2019
|
$
|
827
|
|
|
2020
|
$
|
656
|
|
|
2021
|
$
|
472
|
|
|
2022
|
$
|
323
|
|
|
|
Pension Benefits
|
||||||
|
|
(in thousands)
|
||||||
|
|
For the Three Months Ended October 31,
|
||||||
|
|
2016
|
|
2015
|
||||
|
Service cost
|
$
|
467
|
|
|
$
|
489
|
|
|
Interest cost
|
457
|
|
|
483
|
|
||
|
Expected return on plan assets
|
(476
|
)
|
|
(477
|
)
|
||
|
Amortization of:
|
|
|
|
||||
|
Prior service costs
|
1
|
|
|
2
|
|
||
|
Other actuarial loss
|
429
|
|
|
287
|
|
||
|
Net periodic benefit cost
|
$
|
878
|
|
|
$
|
784
|
|
|
|
|
|
|
||||
|
|
Postretirement Health Benefits
|
||||||
|
|
(in thousands)
|
||||||
|
|
For the Three Months Ended October 31,
|
||||||
|
|
2016
|
|
2015
|
||||
|
Service cost
|
$
|
30
|
|
|
$
|
22
|
|
|
Interest cost
|
18
|
|
|
20
|
|
||
|
Amortization of:
|
|
|
|
||||
|
Prior service costs
|
(2
|
)
|
|
(2
|
)
|
||
|
Other actuarial loss
|
6
|
|
|
—
|
|
||
|
Net periodic benefit cost
|
$
|
52
|
|
|
$
|
40
|
|
|
|
Pension Benefits
|
|
Postretirement Health Benefits
|
||||||||
|
|
For the Three Months Ended October 31,
|
||||||||||
|
|
2016
|
|
2015
|
|
2016
|
|
2015
|
||||
|
Discount rate for net periodic benefit cost
|
3.36
|
%
|
|
4.22
|
%
|
|
2.71
|
%
|
|
3.51
|
%
|
|
Rate of increase in compensation levels
|
3.50
|
%
|
|
3.50
|
%
|
|
—
|
|
|
—
|
|
|
Long-term expected rate of return on assets
|
7.50
|
%
|
|
7.50
|
%
|
|
—
|
|
|
—
|
|
|
|
|
|
|
|
Assets
|
||||||||||
|
|
|
|
|
|
October 31, 2016
|
|
July 31, 2016
|
||||||||
|
|
|
|
|
|
(in thousands)
|
||||||||||
|
Business to Business Products
|
|
$
|
60,368
|
|
|
$
|
61,007
|
|
|||||||
|
Retail and Wholesale Products
|
|
92,639
|
|
|
91,626
|
|
|||||||||
|
Unallocated Assets
|
|
47,060
|
|
|
52,182
|
|
|||||||||
|
Total Assets
|
|
$
|
200,067
|
|
|
$
|
204,815
|
|
|||||||
|
|
|
|
|
|
|
|
|
||||||||
|
|
For the Three Months Ended October 31,
|
||||||||||||||
|
|
Net Sales
|
|
(Loss) Income
|
||||||||||||
|
|
2016
|
|
2015
|
|
2016
|
|
2015
|
||||||||
|
|
(in thousands)
|
||||||||||||||
|
Business to Business Products
|
$
|
27,473
|
|
|
$
|
25,821
|
|
|
$
|
9,408
|
|
|
$
|
9,169
|
|
|
Retail and Wholesale Products
|
39,139
|
|
|
41,974
|
|
|
(507
|
)
|
|
5,402
|
|
||||
|
Total Sales
|
$
|
66,612
|
|
|
$
|
67,795
|
|
|
|
|
|
||||
|
Corporate Expenses
|
|
(5,855
|
)
|
|
(6,795
|
)
|
|||||||||
|
Income from Operations
|
|
3,046
|
|
|
7,776
|
|
|||||||||
|
Total Other Expense, Net
|
|
(367
|
)
|
|
(236
|
)
|
|||||||||
|
Income before Income Taxes
|
|
2,679
|
|
|
7,540
|
|
|||||||||
|
Income Taxes
|
|
(670
|
)
|
|
(2,117
|
)
|
|||||||||
|
Net Income
|
|
$
|
2,009
|
|
|
$
|
5,423
|
|
|||||||
|
|
|
|
|
|
|
|
|
|
|
Number of Shares
|
|
Weighted Average Exercise Price
|
|
Weighted Average Remaining Contractual Term
|
|
Aggregate Intrinsic Value
|
|||||
|
|
(in thousands)
|
|
|
|
(Years)
|
|
(in thousands)
|
|||||
|
Options outstanding and exercisable, July 31, 2016
|
10
|
|
|
$
|
17.00
|
|
|
0.3
|
|
$
|
205
|
|
|
Options outstanding and exercisable, October 31, 2016
|
10
|
|
|
$
|
17.00
|
|
|
0.1
|
|
$
|
168
|
|
|
|
Restricted Shares
(in thousands)
|
|
Weighted Average Grant Date Fair Value
|
|||
|
Non-vested restricted stock outstanding at July 31, 2016
|
194
|
|
|
$
|
29.09
|
|
|
Granted
|
13
|
|
|
$
|
34.21
|
|
|
Vested
|
(37
|
)
|
|
$
|
26.09
|
|
|
Non-vested restricted stock outstanding at October 31, 2016
|
170
|
|
|
$
|
30.11
|
|
|
|
Pension and Postretirement Health Benefits
|
|
Cumulative Translation Adjustment
|
|
Total Accumulated Other Comprehensive (Loss) Income
|
||||||
|
Balance as of July 31, 2016
|
$
|
(13,867
|
)
|
|
$
|
(155
|
)
|
|
$
|
(14,022
|
)
|
|
Other comprehensive loss before reclassifications, net of tax
|
—
|
|
|
(14
|
)
|
|
(14
|
)
|
|||
|
Amounts reclassified from accumulated other comprehensive income, net of tax
|
269
|
|
a)
|
—
|
|
|
269
|
|
|||
|
Net current-period other comprehensive income (loss), net of tax
|
269
|
|
|
(14
|
)
|
|
255
|
|
|||
|
Balance as of October 31, 2016
|
$
|
(13,598
|
)
|
|
$
|
(169
|
)
|
|
$
|
(13,767
|
)
|
|
|
For the Three Months Ended October 31,
|
||||||
|
|
2016
|
|
2015
|
||||
|
Net cash provided by operating activities
|
$
|
1,325
|
|
|
$
|
8,516
|
|
|
Net cash provided by (used in) investing activities
|
533
|
|
|
(2,965
|
)
|
||
|
Net cash used in financing activities
|
(4,554
|
)
|
|
(4,677
|
)
|
||
|
Effect of exchange rate changes on cash and cash equivalents
|
58
|
|
|
(1
|
)
|
||
|
Net (decrease) increase in cash and cash equivalents
|
$
|
(2,638
|
)
|
|
$
|
873
|
|
|
|
Payments Due by Period
|
||||||||||||||||||
|
Contractual Obligations
|
Total
|
|
Less Than 1 Year
|
|
1 – 3 Years
|
|
4 – 5 Years
|
|
After 5 Years
|
||||||||||
|
Notes Payable
|
$
|
12,333
|
|
|
$
|
3,083
|
|
|
$
|
6,167
|
|
|
$
|
3,083
|
|
|
$
|
—
|
|
|
Interest on Notes Payable
|
1,231
|
|
|
498
|
|
|
611
|
|
|
122
|
|
|
—
|
|
|||||
|
Operating Leases
|
16,208
|
|
|
2,028
|
|
|
3,567
|
|
|
1,614
|
|
|
8,999
|
|
|||||
|
Total Contractual Cash Obligations
|
$
|
29,772
|
|
|
$
|
5,609
|
|
|
$
|
10,345
|
|
|
$
|
4,819
|
|
|
$
|
8,999
|
|
|
|
Amount of Commitment Expiration Per Period
|
||||||||||||||||||
|
|
Total
|
|
Less Than 1 Year
|
|
1 – 3 Years
|
|
4 – 5 Years
|
|
After 5 Years
|
||||||||||
|
Other Commercial Commitments
|
$
|
26,395
|
|
|
$
|
26,395
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
ISSUER PURCHASES OF EQUITY SECURITIES
1
|
||||||||
|
|
|
(a)
|
|
(b)
|
|
(c)
|
|
(d)
|
|
For the Three Months Ended October 31, 2016
|
|
Total Number of Shares Purchased
|
|
Average Price Paid per Share
|
|
Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs
|
|
Maximum Number of Shares that may yet be Purchased Under Plans or Programs
2
|
|
August 1, 2016 to August 31, 2016
|
|
—
|
|
—
|
|
—
|
|
305,361
|
|
September 1, 2016 to September 30, 2016
|
|
—
|
|
—
|
|
—
|
|
305,361
|
|
October 1, 2016 to
October 31, 2016 |
|
3,524
|
|
$34.56
|
|
—
|
|
301,837
|
|
Exhibit
No.
|
|
Description
|
|
SEC Document Reference
|
|
|
|
|
|
|
|
11
|
|
Statement re: Computation of Earnings per Share.
|
|
Filed herewith.
|
|
|
|
|
|
|
|
31
|
|
Certifications pursuant to Rule 13a–14(a).
|
|
Filed herewith.
|
|
|
|
|
|
|
|
32
|
|
Certifications pursuant to Section 1350 of the Sarbanes-Oxley Act of 2002.
|
|
Furnished herewith.
|
|
|
|
|
|
|
|
95
|
|
Mine Safety Disclosures
|
|
Filed herewith.
|
|
|
|
|
|
|
|
101.INS
|
|
XBRL Taxonomy Instance Document
|
|
Filed herewith.
|
|
|
|
|
|
|
|
101.SCH
|
|
XBRL Taxonomy Extension Schema Document
|
|
Filed herewith.
|
|
|
|
|
|
|
|
101.CAL
|
|
XBRL Taxonomy Extension Calculation Linkbase Document
|
|
Filed herewith.
|
|
|
|
|
|
|
|
101.DEF
|
|
XBRL Taxonomy Extension Definition Linkbase Document
|
|
Filed herewith.
|
|
|
|
|
|
|
|
101.LAB
|
|
XBRL Taxonomy Extension Labels Linkbase Document
|
|
Filed herewith.
|
|
|
|
|
|
|
|
101.PRE
|
|
XBRL Taxonomy Extension Presentation Linkbase
|
|
Filed herewith.
|
|
Exhibit No.
|
|
Description
|
|
|
|
|
|
|
|
11
|
|
|
Statement re: Computation of Earnings per Share.
|
|
|
|
|
|
|
31
|
|
|
Certifications pursuant to Rule 13a–14(a).
|
|
|
|
|
|
|
32
|
|
|
Certifications pursuant to Section 1350 of the Sarbanes-Oxley Act of 2002.
|
|
|
|
|
|
|
95
|
|
|
Mine Safety Disclosures
|
|
|
|
|
|
|
101.INS
|
|
|
XBRL Taxonomy Instance Document
|
|
|
|
|
|
|
101.SCH
|
|
|
XBRL Taxonomy Extension Schema Document
|
|
|
|
|
|
|
101.CAL
|
|
|
XBRL Taxonomy Extension Calculation Linkbase Document
|
|
|
|
|
|
|
101.DEF
|
|
|
XBRL Taxonomy Extension Definition Linkbase Document
|
|
|
|
|
|
|
101.LAB
|
|
|
XBRL Taxonomy Extension Labels Linkbase Document
|
|
|
|
|
|
|
101.PRE
|
|
|
XBRL Taxonomy Extension Presentation Linkbase
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|